Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 20884287)

1.

Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification.

Yan CS, Hanafi I, Kelleher AD, Carr AD, Amin J, McNally LP, Cunningham PH.

J Clin Virol. 2010 Dec;49(4):249-53. doi: 10.1016/j.jcv.2010.08.016. Epub 2010 Sep 29.

PMID:
20884287
2.

Performance evaluation of the COBAS/TaqMan HIV-1 v2.0 in HIV-1 positive patients with low viral load: a comparative study.

Paba P, Fabeni L, Ciccozzi M, Perno CF, Ciotti M.

J Virol Methods. 2011 May;173(2):399-402. doi: 10.1016/j.jviromet.2011.03.014. Epub 2011 Mar 16.

PMID:
21419171
3.

Problems in the interpretation of HIV-1 viral load assays using commercial reagents.

O'Shea S, Chrystie I, Cranston R, Mullen J, Corbett K, Murphy G, Parry JV, De Ruiter A, Banatvala J.

J Med Virol. 2000 Jun;61(2):187-94.

PMID:
10797373
4.

Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.

Wirden M, Tubiana R, Marguet F, Leroy I, Simon A, Bonmarchand M, Ait-Arkoub Z, Murphy R, Marcelin AG, Katlama C, Calvez V.

J Clin Microbiol. 2009 May;47(5):1543-5. doi: 10.1128/JCM.02134-08. Epub 2009 Mar 18.

5.

Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.

Holguín A, de Mendoza C, Soriano V.

Eur J Clin Microbiol Infect Dis. 1999 Apr;18(4):256-9.

PMID:
10385013
6.

Evaluation of the NucliSens EasyQ HIV-1 v1.1 and RealTime HIV-1 kits for quantitation of HIV-1 RNA in plasma.

Choi JY, Kim EJ, Rho HJ, Kim JY, Kwon OK, Lee JH, Koo MJ, Kim SS.

J Virol Methods. 2009 Oct;161(1):7-11. doi: 10.1016/j.jviromet.2009.02.003. Epub 2009 Feb 12.

PMID:
19576640
7.

Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.

Pas S, Rossen JW, Schoener D, Thamke D, Pettersson A, Babiel R, Schutten M.

J Clin Microbiol. 2010 Apr;48(4):1195-200. doi: 10.1128/JCM.01832-09. Epub 2010 Feb 17.

8.
9.

Comparative evaluation of the VERSANT HIV-1 RNA 1.0 kinetic PCR molecular system (kPCR) for the quantification of HIV-1 plasma viral load.

Ruelle J, Jnaoui K, Lefèvre I, Lamarti N, Goubau P.

J Clin Virol. 2009 Apr;44(4):297-301. doi: 10.1016/j.jcv.2009.01.004. Epub 2009 Feb 18.

PMID:
19230753
10.

Increased frequency of HIV-1 viral load blips associated with introduction of Roche Ampliprep/TaqMan assay.

Fulton RB, Fernando SL.

Pathology. 2011 Apr;43(3):275-6. doi: 10.1097/PAT.0b013e3283437c9a. No abstract available.

PMID:
21436640
11.

Comparative evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 version 2 test using the TaqMan 48 analyzer and the Abbott RealTime HIV-1 assay.

van Rensburg EJ, Tait K, Watt A, Schall R.

J Clin Microbiol. 2011 Jan;49(1):377-9. doi: 10.1128/JCM.01285-10. Epub 2010 Oct 27.

12.

Performance of the new Roche Cobas AmpliPrep-Cobas TaqMan version 2.0 human immunodeficiency virus type 1 assay.

Scott L, Carmona S, Stevens W.

J Clin Microbiol. 2009 Oct;47(10):3400-2. doi: 10.1128/JCM.00727-09. Epub 2009 Aug 5. No abstract available.

13.

Evaluation of the Abbott LCx quantitative assay for measurement of human immunodeficiency virus RNA in plasma.

de Mendoza C, Alcamí J, Sainz M, Folgueira D, Soriano V.

J Clin Microbiol. 2002 Apr;40(4):1518-21.

14.

Health care industries' perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assay.

Elbeik T, Loftus RA, Beringer S.

Expert Rev Mol Diagn. 2002 May;2(3):275-85.

PMID:
12050866
15.

Performance of the Abbott RealTime HIV-1 viral load assay is not impacted by integrase inhibitor resistance-associated mutations.

Young TP, Cloherty G, Fransen S, Napolitano L, Swanson P, Herman C, Parkin NT, Hackett J Jr.

J Clin Microbiol. 2011 Apr;49(4):1631-4. doi: 10.1128/JCM.02253-10. Epub 2011 Feb 2.

16.

The measurement of HIV-1 viral load in resource-limited settings: how and where?

Rouet F, Rouzioux C.

Clin Lab. 2007;53(3-4):135-48. Review.

PMID:
17447649
17.

Performance of the automated COBAS AmpliPrep/COBAS TaqMan HIV-1 test on a genetically diverse panel of specimens from China: comparison to the COBAS amplicor HIV-1 monitor test, v1.5.

Xu S, Song A, Li X, Nie J, Zhang C, Wang Y.

Intervirology. 2010;53(4):221-8. doi: 10.1159/000299064. Epub 2010 Mar 23.

PMID:
20332651
18.

Viral load test reports: a description of content from a sample of US laboratories.

Francis DP, Peddecord KM, Hofherr LK, Astles JR, Schalla WO.

Arch Pathol Lab Med. 2001 Dec;125(12):1546-54.

PMID:
11735688
19.

Plasma load discrepancies between the Roche Cobas Amplicor human immunodeficiency virus type 1 (HIV-1) Monitor version 1.5 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 assays.

Yao JD, Germer JJ, Damond F, Roquebert B, Descamps D.

J Clin Microbiol. 2008 Feb;46(2):834; author reply 834. doi: 10.1128/JCM.02144-07. No abstract available.

20.

Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes.

Chew CB, Herring BL, Zheng F, Browne C, Saksena NK, Cunningham AL, Dwyer DE.

J Clin Virol. 1999 Oct;14(2):87-94.

PMID:
10588451
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk